Mhealth and Teach-Back Effectiveness In 30-Day Readmissions Reduction
Effectiveness of Mhealth and Teach-back Methods in Readmissions Reduction in Prime Minister's National Health Programme - A Feasibility Randomized Controlled Trial
1 other identifier
interventional
270
1 country
1
Brief Summary
The Study is a feasibility randomized controlled trial aiming to assess the feasibility of mHealth (voice call and SMS) and teach-back interventions on reducing the 30 days readmission rate in the patients enrolled in the Sehat Sahulat Programme (Prime Minister National Health Programme(PMNHP)). The prime objective of this study was to generate a proof of concept for the conduct of a definitive trial for the reduction in readmissions in PMNHP. A feasibility randomized controlled trial study consisted of three arms i.e intervention 1 (telephonic contact and text messages), intervention 2 (teach-back method) and control is planned in program beneficiaries of Islamabad, Pakistan. The trial is being carried out in the three hospitals of Islamabad and patients are being recruited as per the inclusion and exclusion criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFebruary 10, 2021
February 1, 2021
1 year
January 21, 2021
February 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Readmission within 7 days post discharge
7 Days after discharge, participants were assessed for readmission.
7 days post discharge.
Readmission within 14 days post discharge
14 Days after discharge, participants were assessed for readmission.
14 days post discharge.
Readmission within 21 days post discharge
21 Days after discharge, participants were assessed for readmission
21 Days post discharge
Readmission within 30 days post discharge
30 Days after discharge, participants were assessed for readmission
30 Days post discharge
Study Arms (3)
Control Arm
NO INTERVENTIONNo intervention is being conducted in this arm. Routine care is being given to these patients. The patients will be followed up for any readmissions during the intervention period.
mHealth Arm
EXPERIMENTALThis arm will receive first receive weekly telephone call followed by the SMS in Urdu regarding medication adherence according to the discharge instructions. The calls and SMS will be sent on 7, 14, 21 and 30th day post-index discharge. The patients will be followed up for any readmissions during the intervention period.
Teach back arm
EXPERIMENTALThe trained doctors thoroughly explained the discharge instructions, medication schedule and any other self-care instructions to these participants and asked them to repeat what they have understood from the doctor verbal counselling. If the instructions were not clearly comprehended by the patients, then the same would be repeated by the consultant doctor. The patients will be followed up for any readmissions during the intervention period.
Interventions
While the teach-back includes counselling session related to discharge instruction including medication adherence.
Eligibility Criteria
You may qualify if:
- Adult patients \> 30 years of age
- Incident adult cases with index admission in PMNHP
- Ischemic Heart disease, Myocardial Infarction, Hypertension, Diabetes Mellitus, Bronchial Asthma
- Patients with a valid mobile number
- Able to read the SMS in Urdu
You may not qualify if:
- Serious mental illness such as schizophrenia,
- Are unable to use a telephone
- Are cognitively impaired during hospitalization as diagnosed by the consultant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alkhidmat AlRazi Hospital
Islamabad, Punjab Province, 46000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Assad Hafeez, PhD
Health Services Academy, Pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Fellow
Study Record Dates
First Submitted
January 21, 2021
First Posted
February 4, 2021
Study Start
March 1, 2020
Primary Completion
March 1, 2021
Study Completion
June 1, 2021
Last Updated
February 10, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share